Journal of veterinary pharmacology and therapeutics·2001
Methadone impacts brain activity and attention differently in patients based on their baseline brainwave patterns. Type B patients showed improved attention, while Type A patients experienced physiological changes.
Area of Science:
Neuroscience
Psychopharmacology
Clinical Psychology
Background:
Methadone maintenance treatment (MMT) is a cornerstone for opioid use disorder.
Understanding methadone's acute effects on cognitive and psychophysiological functions is crucial for optimizing treatment.
Individual variability in response to MMT necessitates exploring patient-specific factors.
Purpose of the Study:
To investigate the acute effects of methadone on brain functioning, attention, and psychophysiology in MMT patients.
To identify distinct patient subgroups based on baseline brain activity (contingent negative variation - CNV).
To determine if methadone's effects differ between these identified patient subgroups.
Main Methods:
Twelve male MMT outpatients were administered acute methadone doses.
Brain functioning was assessed using contingent negative variation (CNV).
Attention was evaluated via reaction time and the continuous performance test.
Psychophysiological activity included heart rate and eye blink rate monitoring.
Patients were categorized into Type A (quick CNV rise) and Type B (slow CNV rise) based on basal CNV shapes.
Main Results:
Methadone increased contingent negative variation (CNV) and enhanced attention performance in Type B patients.
Methadone elevated heart rate and decreased eye blink rate in Type A patients.
Individual differences in basal CNV shape predicted differential responses to acute methadone administration.
Conclusions:
Acute methadone administration produces distinct neurocognitive and psychophysiological effects contingent on baseline CNV patterns.
Findings support the distraction-arousal hypothesis for Type B responders and the eye blink-hedonia hypothesis for Type A responders.
Subgrouping patients based on electrophysiological measures may refine our understanding of methadone's therapeutic mechanisms and side effects.